当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Rotaru DI, Moga RA and Avram R
Introduction: Due to its spread and implications, oral lichen planus has attracted particular attention from the medical world. Despite efforts, the etiology of oral lichen planus is currently incompletely understood. Establishing significant associations between oral lichen planus and hepatitis viruses helps to identify the population that requires screening for the markers of these viruses and implicitly, to diagnose these hepatitis cases.
Aims: To determine the frequency of association of oral lichen planus with HCV infection and to establish a correlation between the severity of hepatic involvement and that of lichen planus lesions.
Material and methods: Included 80 patients with oral lichen planus. All patients included in the study underwent biochemical liver function tests. Statistical analysis of clinical and para-clinical parameters was performed.
Results: The group of HCV-positive patients with oral lichen planus represented 42.5% of the study group. It was found that oral lichen planus with reticular lesions was the predominant clinical form. Regarding the relationship between the severity of oral lichen planus lesions and that of hepatic involvement, no correlation could be established between the degree of alteration of liver function tests and the severity of oral lesions. Thus, patients with high transaminase values had non-extensive lesions and mild, non-painful reticular forms, while other patients with normal or slightly changed liver function test values had extensive, particularly painful erosive lesions, with an altered general status.
Conclusions: There is no significant correlation between the degree of alteration of liver function tests and the severity of oral lesions. Oral erosive lesions had a significantly higher incidence in patients with at least one changed liver function test.